Among the antiviral activities that melatonin has, by suppressing multiple inflammatory pathways (e.g., IL6 and IL-1β), these effects are directly relevant given the well-described pulmonary pathophysiological characteristics of patients with severe COVID-19. Here, IL6 is linked to COVID-19.